Related Experiment Video
Updated: Oct 4, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
Reduced expression of cell-cycle regulator p27(Kip1) correlates with a shortened survival in non-small cell lung
S Tsukamoto1, K Sugio, T Sakada
1Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan.
Background:
The cell cycle progression is governed by a family of cyclin-dependent kinases, which are regulated by associated cyclins and by phosphorylation. p27, a cyclin-dependent kinase inhibitor, regulates the progression from G1 into the S phase by binding and inhibiting cyclin/cdks. Although p27 mutations in human tumors are extremely rare, a reduced expression of p27 might to lead to a progression of cancer cells.
Methods:
We examined tissues that had been surgically excised from 161 unselected Japanese patients with non-small cell lung cancer, and investigated the p27 protein expression by immunohistochemistry.
Results:
A reduced expression of the p27 protein was found in 63 cases (39.0%). Statistical correlation was found between the reduced p27 expression and advanced stage, although no correlation was found between the level of p27 expression and the gender, T factor, N factor or histological differentiation. The 5-year survival rate in the reduced group was 35.4%, which was statistically poorer than the 63.2% rate in the normal group (P=0.0016), in patients with complete resection. In a multivariate analysis, the level of p27 expression was found to be an independent prognostic indicator.
Conclusions:
We demonstrated the expression of p27 protein to be a biological prognostic indicator which can indicate the subsets of patients with either a good or poor prognosis, in patients who underwent surgical resection.
Insights
Reduced expression of p27 protein, a cell cycle regulator, is linked to advanced non-small cell lung cancer. Lower p27 levels indicate a poorer prognosis and reduced survival rates in patients after surgical resection.
Area of Science:
- Molecular Biology
- Oncology
- Cell Cycle Regulation
Background:
- Cell cycle progression is controlled by cyclin-dependent kinases (CDKs), regulated by cyclins and phosphorylation.
- p27, a cyclin-dependent kinase inhibitor (CKI), controls G1 to S phase transition by inhibiting cyclin/CDKs.
- Reduced p27 expression, not mutations, may drive cancer progression.
Purpose of the Study:
- To investigate the role of p27 protein expression in non-small cell lung cancer (NSCLC).
- To determine if p27 expression levels correlate with clinicopathological features and patient prognosis.
Main Methods:
- Analyzed surgically excised tissues from 161 Japanese NSCLC patients.
- Assessed p27 protein expression using immunohistochemistry.
Main Results:
- Reduced p27 expression was observed in 39.0% of cases.
- Lower p27 levels correlated with advanced NSCLC stage.
- Reduced p27 expression was an independent poor prognostic indicator, associated with significantly lower 5-year survival rates in patients with complete resection.
Conclusions:
- p27 protein expression serves as a valuable prognostic biomarker in NSCLC.
- It helps identify patient subsets with good or poor prognosis following surgical resection.
Related Concept Videos
Inhibition of Cdk Activity
Negative Regulator Molecules
Abnormal Proliferation
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...